MIRA PHARMACEUTICALS, INC. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (2)
- Human Resources (8)
- Intellectual Property (3)
- Real Estate (1)
- Amendment to Employment Agreement, dated October 13, 2023, between MIRA Pharmaceuticals and Dr. Chris Chapman (Filed With SEC on December 18, 2023)
- Exclusive License Agreement, by and between the Company and MIRALOGX, dated as of November 30, 2023 (Filed With SEC on November 20, 2023)
- Common Stock Purchase Warrant from the Company to MIRALOGX, dated November 15, 2023 (Filed With SEC on November 20, 2023)
- Promissory Note and Loan Agreement, by and between the Company and MIRALOGX, dated as of November 15, 2023 (Filed With SEC on November 20, 2023)
- Amendment to Employment Agreement, August 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (Filed With SEC on August 31, 2023)
- Amendment to Employment Agreement, dated August 28, 2023, between MIRA Pharmaceuticals and Dr. Chris Chapman (Filed With SEC on August 31, 2023)
- Underwriting Agreement, dated as of August 2, 2023, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (Filed With SEC on August 7, 2023)
- Representatives Warrant, dated August 7, 2023 (Filed With SEC on August 7, 2023)
- Conversion Agreement, dated July 20, 2023, between MIRA Pharmaceuticals, Inc. and the Bay Shore Trust (Filed With SEC on July 21, 2023)
- Form of Underwriting Agreement (Filed With SEC on July 18, 2023)
- Form of Representatives Warrant (Filed With SEC on July 18, 2023)
- Common Stock Purchase Warrant, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on July 14, 2023)
- Agreement for Shared Lease Costs, dated April 1, 2023, between MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc., and MIRALOGX, LLC (Filed With SEC on July 14, 2023)
- Master Collaboration Agreement, dated November 1, 2021, between MIRA Pharmaceuticals, Inc. and The Johns Hopkins University (Filed With SEC on July 14, 2023)
- Common Stock Purchase Warrant, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)
- 2022 Omnibus Incentive Plan, as amended and restated (Filed With SEC on June 29, 2023)
- Form of Stock Option Award under 2022 Omnibus Incentive Plan (Filed With SEC on June 29, 2023)
- Form of Indemnification Agreement (Filed With SEC on June 29, 2023)
- Confirmatory Patent Assignment and Royalty Agreement, dated November 1, 2021, between SRQ Patent Holdings II, LLC and MIRA Pharmaceuticals, Inc (Filed With SEC on June 29, 2023)
- Amended and Restated Limited License Agreement, dated June 27, 2022, between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc (Filed With SEC on June 29, 2023)
- Amendment No. 1, dated April 20, 2023, to Amended and Restated Limited License Agreement between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc (Filed With SEC on June 29, 2023)
- Employment Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (Filed With SEC on June 29, 2023)
- Employment Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Michele Yanez (Filed With SEC on June 29, 2023)
- Employment Agreement between MIRA Pharmaceuticals, Inc. and Chris Chapman to become effective upon the completion of this offering (Filed With SEC on June 29, 2023)
- Promissory Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)
- Registration Rights Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on June 29, 2023)